Brief: Sunesis Pharmaceuticals - Appointed Dayton Misfeldt, Co's Interim CEO, As Principal Financial Officer

Viracta Therapeutics

01/05/2020 22:23

May 1 (Reuters) - Sunesis Pharmaceuticals Inc  SNSS.O :
    * SUNESIS PHARMACEUTICALS - ON APRIL 28, APPOINTED DAYTON
MISFELDT, CO'S INTERIM CEO, AS PRINCIPAL FINANCIAL OFFICER &
SECRETARY, EFFECTIVE MAY 1, 2020

Source text for Eikon: https://bit.ly/2YB4gfx
Further company coverage:  SNSS.O 

 ((Briefs@thomsonreuters.com;))